Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Bruker (BRKRP) Change in Cash (2016 - 2025)

Bruker's Change in Cash history spans 16 years, with the latest figure at $5.8 million for Q4 2025.

  • For Q4 2025, Change in Cash fell 83.43% year-over-year to $5.8 million; the TTM value through Dec 2025 reached $116.4 million, up 138.18%, while the annual FY2025 figure was $116.4 million, 138.18% up from the prior year.
  • Change in Cash reached $5.8 million in Q4 2025 per BRKRP's latest filing, down from $201.1 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $495.2 million in Q4 2021 to a low of -$252.1 million in Q1 2022.
  • Average Change in Cash over 5 years is -$19.1 million, with a median of -$29.2 million recorded in 2021.
  • Peak YoY movement for Change in Cash: crashed 1791.95% in 2022, then skyrocketed 1035.35% in 2025.
  • A 5-year view of Change in Cash shows it stood at $495.2 million in 2021, then plummeted by 96.08% to $19.4 million in 2022, then skyrocketed by 542.78% to $124.7 million in 2023, then tumbled by 71.93% to $35.0 million in 2024, then tumbled by 83.43% to $5.8 million in 2025.
  • Per Business Quant, the three most recent readings for BRKRP's Change in Cash are $5.8 million (Q4 2025), $201.1 million (Q3 2025), and -$91.5 million (Q2 2025).